Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs. 30 crores during FY 2024 and Rs. 7 crores in Q1 FY 2025
Critical resources will help Genvor to grow and scale biological crop protection products and innovative trait technologies
The grant is designated for the research and development of Pyronaridine
Higher revenues backed by huge demand and expanding network contributed to the growth in bottom line
The tele-icu services which had a soft launch four months ago have already provided valuable assistance to 250+ patients in some of the remotest villages in India
This product will be manufactured by Indoco at its manufacturing facility located at L-14, Verna Industrial Area, Verna, Goa in India
The company recorded sales of Rs. 1,129 crore for the fiscal year ended June 30, 2024,
The emergence of new infections in India is a growing concern
Becomes the first rehab & recovery center in east India to earn NABH accreditation
European markets now contribute 51% of our business revenue up from 43% in Q4 FY24 and 34% in Q1 FY24
Subscribe To Our Newsletter & Stay Updated
